Cargando…
Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma
BACKGROUND: In recent years, the concept of liquid biopsy diagnostics in detection and progress monitoring of malignant diseases gained significant awareness. We here report on a semi-quantitative real-time cytokeratin 20 RT-PCR-based assay, for detecting circulating tumor cells within a fraction of...
Autores principales: | Hendricks, Alexander, Eggebrecht, Greta-Lou, Bernsmeier, Alexander, Geisen, Reinhild, Dall, Katharina, Trauzold, Anna, Becker, Thomas, Kalthoff, Holger, Schafmayer, Clemens, Röder, Christian, Hinz, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007960/ https://www.ncbi.nlm.nih.gov/pubmed/29937995 http://dx.doi.org/10.18632/oncotarget.25384 |
Ejemplares similares
-
Longitudinal Analysis of Circulating Tumor Cells in Colorectal Cancer Patients by a Cytological and Molecular Approach: Feasibility and Clinical Application
por: Hendricks, Alexander, et al.
Publicado: (2021) -
Isolation and Enumeration of CTC in Colorectal Cancer Patients: Introduction of a Novel Cell Imaging Approach and Comparison to Cellular and Molecular Detection Techniques
por: Hendricks, Alexander, et al.
Publicado: (2020) -
Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
por: Hinz, Sebastian, et al.
Publicado: (2015) -
Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients – a prospective study
por: Hinz, Sebastian, et al.
Publicado: (2017) -
Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy
por: Hendricks, Alexander, et al.
Publicado: (2020)